CN109400669B - 核桃仁皮的小分子蛋白质提取方法及应用 - Google Patents
核桃仁皮的小分子蛋白质提取方法及应用 Download PDFInfo
- Publication number
- CN109400669B CN109400669B CN201811486049.7A CN201811486049A CN109400669B CN 109400669 B CN109400669 B CN 109400669B CN 201811486049 A CN201811486049 A CN 201811486049A CN 109400669 B CN109400669 B CN 109400669B
- Authority
- CN
- China
- Prior art keywords
- walnut kernel
- protein
- kernel skin
- small molecular
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000020234 walnut Nutrition 0.000 title claims abstract description 92
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 89
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 89
- 235000009496 Juglans regia Nutrition 0.000 title claims abstract description 88
- 238000000605 extraction Methods 0.000 title abstract description 6
- 240000007049 Juglans regia Species 0.000 title 1
- 241000758789 Juglans Species 0.000 claims abstract description 87
- 238000000034 method Methods 0.000 claims abstract description 18
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 16
- 241000194032 Enterococcus faecalis Species 0.000 claims abstract description 15
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims abstract description 15
- 229940032049 enterococcus faecalis Drugs 0.000 claims abstract description 15
- 230000001093 anti-cancer Effects 0.000 claims abstract description 8
- 201000006585 gastric adenocarcinoma Diseases 0.000 claims abstract description 7
- 229940124350 antibacterial drug Drugs 0.000 claims abstract description 5
- 201000007270 liver cancer Diseases 0.000 claims abstract description 4
- 208000014018 liver neoplasm Diseases 0.000 claims abstract description 4
- 239000006228 supernatant Substances 0.000 claims description 10
- 238000000227 grinding Methods 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 7
- 229920005654 Sephadex Polymers 0.000 claims description 5
- 239000012507 Sephadex™ Substances 0.000 claims description 5
- 238000002835 absorbance Methods 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 150000003384 small molecules Chemical class 0.000 claims description 5
- 241000758791 Juglandaceae Species 0.000 claims description 4
- 239000000022 bacteriostatic agent Substances 0.000 claims description 4
- 239000012530 fluid Substances 0.000 claims description 4
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 claims description 3
- 238000010521 absorption reaction Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000002523 gelfiltration Methods 0.000 claims description 3
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 238000005119 centrifugation Methods 0.000 claims description 2
- 239000002842 anticancer formulation Substances 0.000 claims 2
- 238000004587 chromatography analysis Methods 0.000 claims 2
- 235000018102 proteins Nutrition 0.000 abstract description 70
- 230000000694 effects Effects 0.000 abstract description 9
- 230000004083 survival effect Effects 0.000 abstract description 7
- 238000012360 testing method Methods 0.000 abstract description 7
- 101000600434 Homo sapiens Putative uncharacterized protein encoded by MIR7-3HG Proteins 0.000 abstract description 6
- 102100037401 Putative uncharacterized protein encoded by MIR7-3HG Human genes 0.000 abstract description 6
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 6
- 238000011160 research Methods 0.000 abstract description 6
- 230000004663 cell proliferation Effects 0.000 abstract description 5
- 230000009471 action Effects 0.000 abstract description 4
- 238000010266 Sephadex chromatography Methods 0.000 abstract description 2
- 235000004252 protein component Nutrition 0.000 abstract description 2
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 229940041181 antineoplastic drug Drugs 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 22
- 239000000243 solution Substances 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 9
- 238000000502 dialysis Methods 0.000 description 8
- 244000005700 microbiome Species 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 230000003385 bacteriostatic effect Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 210000002540 macrophage Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000009210 therapy by ultrasound Methods 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000001641 gel filtration chromatography Methods 0.000 description 3
- 210000003292 kidney cell Anatomy 0.000 description 3
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 239000012460 protein solution Substances 0.000 description 3
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 3
- 241000588626 Acinetobacter baumannii Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 241000588747 Klebsiella pneumoniae Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241000191963 Staphylococcus epidermidis Species 0.000 description 2
- 241000191984 Staphylococcus haemolyticus Species 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000009036 growth inhibition Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- 229960003284 iron Drugs 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 210000004988 splenocyte Anatomy 0.000 description 2
- 229940037649 staphylococcus haemolyticus Drugs 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 241000194031 Enterococcus faecium Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000863434 Myxococcales Species 0.000 description 1
- 241000555745 Sciuridae Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000192097 Staphylococcus sciuri Species 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- 235000005811 Viola adunca Nutrition 0.000 description 1
- 240000009038 Viola odorata Species 0.000 description 1
- 235000013487 Viola odorata Nutrition 0.000 description 1
- 235000002254 Viola papilionacea Nutrition 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000011394 anticancer treatment Methods 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000007073 chemical hydrolysis Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000017066 negative regulation of growth Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/145—Extraction; Separation; Purification by extraction or solubilisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Analytical Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811486049.7A CN109400669B (zh) | 2018-12-06 | 2018-12-06 | 核桃仁皮的小分子蛋白质提取方法及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811486049.7A CN109400669B (zh) | 2018-12-06 | 2018-12-06 | 核桃仁皮的小分子蛋白质提取方法及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109400669A CN109400669A (zh) | 2019-03-01 |
CN109400669B true CN109400669B (zh) | 2021-08-20 |
Family
ID=65457523
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811486049.7A Active CN109400669B (zh) | 2018-12-06 | 2018-12-06 | 核桃仁皮的小分子蛋白质提取方法及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109400669B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114752585B (zh) * | 2022-05-20 | 2023-07-18 | 山西大学 | 一种核桃青皮抗肿瘤活性蛋白及其制备方法和应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101185671A (zh) * | 2007-12-07 | 2008-05-28 | 贵州大学 | 从核桃树皮中提取的抗肿瘤药物及其制备方法 |
WO2013191565A1 (en) * | 2012-06-18 | 2013-12-27 | Waikatolink Limited | Antimicrobial composition and its method of use |
CN104152520A (zh) * | 2014-07-30 | 2014-11-19 | 华南理工大学 | 一种具有抗肿瘤活性的核桃多肽-锌螯合物的制备方法 |
CN105061382A (zh) * | 2015-08-11 | 2015-11-18 | 张初署 | 一种黑花生衣原花色素和富硒蛋白同步提取方法 |
-
2018
- 2018-12-06 CN CN201811486049.7A patent/CN109400669B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101185671A (zh) * | 2007-12-07 | 2008-05-28 | 贵州大学 | 从核桃树皮中提取的抗肿瘤药物及其制备方法 |
WO2013191565A1 (en) * | 2012-06-18 | 2013-12-27 | Waikatolink Limited | Antimicrobial composition and its method of use |
CN104152520A (zh) * | 2014-07-30 | 2014-11-19 | 华南理工大学 | 一种具有抗肿瘤活性的核桃多肽-锌螯合物的制备方法 |
CN105061382A (zh) * | 2015-08-11 | 2015-11-18 | 张初署 | 一种黑花生衣原花色素和富硒蛋白同步提取方法 |
Non-Patent Citations (5)
Title |
---|
Antioxidant and Anticancer Activities of Walnut (Juglans regia L.) Protein Hydrolysates Using Different Proteases;Raheleh Jahanbani等;《Plant Foods Hum Nut》;20160927;第71卷(第4期);第402-409页 * |
Tannins and Antioxidant Activities of the Walnut (Juglans regia) Pellicle;Tian-Peng Yin等;《Natural Product Communications》;20151227;第10卷(第12期);第2141-2144页 * |
核桃内种皮营养与功能成分初步分析研究;荣瑞芬等;《食品科学》;20081115;第29卷(第11期);第541-543页 * |
核桃蛋白生物活性的研究进展;翟梦新等;《中国食物与营养》;20130628;第19卷(第6期);第62-64页 * |
超声波-微波协同辅助法提取核桃蛋白工艺优化及特性研究;余永婷等;《食品研究与开发》;20181120;第39卷(第22期);第35-40页 * |
Also Published As
Publication number | Publication date |
---|---|
CN109400669A (zh) | 2019-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101853687B1 (ko) | 방사무늬김 추출물의 스테롤 분획물을 포함하는 항염증 조성물 및 방사무늬김 추출물의 스테롤 분획물의 제조방법 | |
CN103882083B (zh) | 一种抗氧化胶原肽的制备方法 | |
JP2019514967A (ja) | 塩生植物由来の機能性が強化した脱塩栄養組成物とその製造方法 | |
WO2016041258A1 (zh) | 一种竹荪多糖-锌螯合物的制备方法及其应用 | |
CN101020715B (zh) | 鹿茸神经生长因子(deer ngf)提取及其制备方法 | |
CN115772550A (zh) | 一种具有抗氧化活性和保肝功效的草菇多肽的制备方法 | |
JP2009500446A (ja) | ケヨノミの抽出物を含む肝臓疾患予防及び治療効果を有する薬剤学的組成物 | |
CN109400669B (zh) | 核桃仁皮的小分子蛋白质提取方法及应用 | |
KR100883399B1 (ko) | 여드름, 아토피 피부 질환 예방 및 치료용 녹차 수용성추출물의 제조방법 | |
JP2002065206A (ja) | 免疫賦活食品 | |
JP4484014B2 (ja) | ヒアルロニダーゼ阻害、抗アレルギー活性および免疫賦活物質 | |
WO2016010182A1 (ko) | 세리포리아 락세라타 배양액 추출물 유래의 세포외다당체를 유효성분으로 함유하는 간기능 개선용 조성물 | |
CN110590908B (zh) | 一种小带鱼源抗菌肽添加剂及其制备方法 | |
CN117820437B (zh) | 菊芋肽、其制备方法及其在护肾辅助糖尿病治疗抗氧化产品中的应用 | |
KR100699782B1 (ko) | 댕댕이나무 추출물을 포함하는 간 기능 회복용 식품 조성물 | |
KR101704123B1 (ko) | 활성아민 함유 봉독의 분리 방법 및 그의 식품 조성물 | |
CN109527583A (zh) | 羊肚菌子实体多肽的新用途 | |
CN105963330B (zh) | 神秘果制剂及其应用 | |
KR102472951B1 (ko) | 좁은잎천선과 혼합 추출물을 유효성분으로 함유하는 면역 증진용 조성물 | |
KR100517354B1 (ko) | 해조류 유래 올리고당, 상기 올리고당의 제조방법 및사용방법 | |
CN105085647A (zh) | 天然抗感染抗氧化双功能肽Pb-CATH2及其基因与应用 | |
JP6324551B2 (ja) | 抗乳癌剤、抗乳癌用食品、乳癌を抑制するための方法及び抗乳癌剤の製造方法 | |
CN108047344A (zh) | 大豆螺旋藻复合提取物的制备方法及其在水松纸上的应用 | |
CN115462530B (zh) | 板栗仁提取物及其提取方法和在抗氧化产品中的应用 | |
RU2563816C1 (ru) | Способ получения иммуностимулятора |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
OL01 | Intention to license declared | ||
OL01 | Intention to license declared | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20190301 Assignee: Yunnan Linkang Biotechnology Co.,Ltd. Assignor: SOUTHWEST FORESTRY University Contract record no.: X2024980006840 Denomination of invention: Extraction Method and Application of Small Molecule Proteins from Walnut Peel Granted publication date: 20210820 License type: Open License Record date: 20240607 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20190301 Assignee: Kunming Zhuote Biotechnology Co.,Ltd. Assignor: SOUTHWEST FORESTRY University Contract record no.: X2024980007439 Denomination of invention: Extraction Method and Application of Small Molecule Proteins from Walnut Peel Granted publication date: 20210820 License type: Open License Record date: 20240624 |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20190301 Assignee: Kunming Xinfan Biotechnology Co.,Ltd. Assignor: SOUTHWEST FORESTRY University Contract record no.: X2024980007426 Denomination of invention: Extraction Method and Application of Small Molecule Proteins from Walnut Peel Granted publication date: 20210820 License type: Open License Record date: 20240624 |